A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group.

Abstract

Our findings suggest that SRH is as safe and effective as IRH in the treatment of cancer pain.